Gestagens in assisted reproductive technology programs
Background. Luteal phase (LP) drug support is an important step in assisted reproductive technology (ART) programs efficacy. Aim. To present up-to-date data on an efficacy of LP hormonal support during ART cycles as well as to conduct a comparative analysis of various gestagen drug effectiveness. Ma...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Berlin A.V.
2019-04-01
|
Series: | Гинекология |
Subjects: | |
Online Access: | https://gynecology.orscience.ru/2079-5831/article/viewFile/33503/pdf |
_version_ | 1818055801151946752 |
---|---|
author | Anastasia G Syrkasheva Yana A Petrosyan Natalia V Dolgushina |
author_facet | Anastasia G Syrkasheva Yana A Petrosyan Natalia V Dolgushina |
author_sort | Anastasia G Syrkasheva |
collection | DOAJ |
description | Background. Luteal phase (LP) drug support is an important step in assisted reproductive technology (ART) programs efficacy. Aim. To present up-to-date data on an efficacy of LP hormonal support during ART cycles as well as to conduct a comparative analysis of various gestagen drug effectiveness. Materials and methods. To write this review domestic and foreign publications were searched in Russian and international search systems (PubMed, eLibrary, etc.) for the last 8 years. The review includs articles from peer-reviewed literature. Results. LP drug support becomes an essential step in infertility treatment in various ART programs. Although human chorionic gonadotropin drug injections in the posttransfer period leads to an activation of endogenous steroid hormones synthesis, exogenous hormones use is currently preferred because of not having a risk of ovarian hyperstimulation syndrome. Conclusions. The variety of progesterone drugs is accompanied by a lack of algorithms for their use in various clinical situations. Further studies are required to evaluate progesterone drugs efficacy for various subgroups of patients. |
first_indexed | 2024-12-10T12:18:43Z |
format | Article |
id | doaj.art-7d9c038a340446b98fbbd7114c4d7875 |
institution | Directory Open Access Journal |
issn | 2079-5696 2079-5831 |
language | Russian |
last_indexed | 2024-12-10T12:18:43Z |
publishDate | 2019-04-01 |
publisher | IP Berlin A.V. |
record_format | Article |
series | Гинекология |
spelling | doaj.art-7d9c038a340446b98fbbd7114c4d78752022-12-22T01:49:08ZrusIP Berlin A.V.Гинекология2079-56962079-58312019-04-01212767910.26442/20795696.2019.2.19023830233Gestagens in assisted reproductive technology programsAnastasia G Syrkasheva0Yana A Petrosyan1Natalia V Dolgushina2V.I.Kulakov National Medical Research Center for Obstetrics, Gynecology and PerinatologyV.I.Kulakov National Medical Research Center for Obstetrics, Gynecology and PerinatologyV.I.Kulakov National Medical Research Center for Obstetrics, Gynecology and PerinatologyBackground. Luteal phase (LP) drug support is an important step in assisted reproductive technology (ART) programs efficacy. Aim. To present up-to-date data on an efficacy of LP hormonal support during ART cycles as well as to conduct a comparative analysis of various gestagen drug effectiveness. Materials and methods. To write this review domestic and foreign publications were searched in Russian and international search systems (PubMed, eLibrary, etc.) for the last 8 years. The review includs articles from peer-reviewed literature. Results. LP drug support becomes an essential step in infertility treatment in various ART programs. Although human chorionic gonadotropin drug injections in the posttransfer period leads to an activation of endogenous steroid hormones synthesis, exogenous hormones use is currently preferred because of not having a risk of ovarian hyperstimulation syndrome. Conclusions. The variety of progesterone drugs is accompanied by a lack of algorithms for their use in various clinical situations. Further studies are required to evaluate progesterone drugs efficacy for various subgroups of patients.https://gynecology.orscience.ru/2079-5831/article/viewFile/33503/pdfinfertilityassisted reproductive technologiesin vitro fertilizationgestagens |
spellingShingle | Anastasia G Syrkasheva Yana A Petrosyan Natalia V Dolgushina Gestagens in assisted reproductive technology programs Гинекология infertility assisted reproductive technologies in vitro fertilization gestagens |
title | Gestagens in assisted reproductive technology programs |
title_full | Gestagens in assisted reproductive technology programs |
title_fullStr | Gestagens in assisted reproductive technology programs |
title_full_unstemmed | Gestagens in assisted reproductive technology programs |
title_short | Gestagens in assisted reproductive technology programs |
title_sort | gestagens in assisted reproductive technology programs |
topic | infertility assisted reproductive technologies in vitro fertilization gestagens |
url | https://gynecology.orscience.ru/2079-5831/article/viewFile/33503/pdf |
work_keys_str_mv | AT anastasiagsyrkasheva gestagensinassistedreproductivetechnologyprograms AT yanaapetrosyan gestagensinassistedreproductivetechnologyprograms AT nataliavdolgushina gestagensinassistedreproductivetechnologyprograms |